• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Services
    • Subscriptions
    • Shop
    • Customised research
    • Telephone conference consultancy
  • Geography
    • Europe
    • Americas
    • Africa
    • Asia
    • Oceania
  • Resources
    • Events

      What’s coming up

    • Podcasts

      Interviews

    • Blogs

      Topical articles on current issues

  • About us
    • Why CannIntelligence?
    • CannIntelligence training center
    • Tamarind Intelligence Group
Logo
Login LoginLogin Free Trial Free TrialFree Trial
  • Services
    • Subscriptions
    • Shop
    • Customised research
    • Telephone conference consultancy
  • Geography
    • Europe
    • Americas
    • Africa
    • Asia
    • Oceania
  • Resources
    • Events

      What’s coming up

    • Podcasts

      Interviews

    • Blogs

      Topical articles on current issues

  • About us
    • Why CannIntelligence?
    • CannIntelligence training center
    • Tamarind Intelligence Group

    More results...

    Filter by Content types
    Regulatory databases
    Regulatory reports
    Market reports
    News analysis
    Filter by Geography
    Africa
    Asia
    Australasia
    Europe
    United Kingdom
    North America
    United States
    South America

    Alerts LATEST ALERTS

    • Costa Rica Health ministry says cannabis should be sold in supermarkets…
    • South Dakota - United States House back medical cannabis fee waiver…
    • United States - Utah House approves changes to medical cannabis rules…
    • United States Judge rules that cannabis users can carry guns…
    • United Kingdom Government considering ACMD advice on CBD products…
    • Laos Health department approves use and production of hemp…
    • Mexico Proposal submitted to regulate hemp…
    • Missouri - United States Recreational cannabis sales have begun…
    • Zimbabwe Bill submitted to remove industrial hemp from dangerous drugs list…
    • France ANSM updates list of places that order and dispense medical cannabis…
    • New Zealand Medical cannabis product meets required supply standards…
    • Mississippi - United States Medical cannabis passed by the House…
    View all
    News analysis

    Legal CBD firms face cash chaos as US Bank cancels their card accounts

    Written by Daniel Mollenkamp || 14th May 2019 || News analysis | Companies | Policy and Politics | Regulation and legislation | North America United States

    cannintelligence
    Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal ...

    Need help?

    Contact a sales representative right now and don’t wait

    Erik Galavis
    +34 654 320 547
    Email Erik

    Restricted content. Do you want to read more?

    Subscribers: Login here
    Login
    Remember me

    Forget? | Register
    Back to Login | Register

    The data or analysis report you have tried to access is restricted to our subscribers. We invite you to take a free trial below where you will get access to a limited set of our content.

    You can find available reports for purchase in our online store. Reports not listed in the store are available under request. If you are interested in a subscription, get in contact to discuss our subscription plans or to upgrade your current access.

    Request report

    Interested in buying?
    Request more information

    MORE INFO

    Visit store

    Check out our reports
    available for purchase

    VIEW REPORTS

    Request a free sample of this report:

    “ Legal CBD firms face cash chaos as US Bank cancels their card accounts ”

      This file is not available, please fill the form to request your sample page:






      Buy report request information:

      “ Legal CBD firms face cash chaos as US Bank cancels their card accounts ”






        Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal ...

        Are you already a subscriber? login here

        Login
        Remember me

        Forget? | Register
        Back to Login | Register

         

        Enjoy free subscription access

        Get access to premium content that is normally only available for subscribers.
        For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.

        I WANT A FREE TRIAL NOW

        Benefits of subscription plans:

        • Stay informed of any legal and market change in the sector that impacts your organization
        • Maximise resources by getting market and legal data analysis daily in one place
        • Make smart decisions by understanding how the regulatory and market landscape evolves
        • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

        Need help?

        Contact a sales representative right now and don’t wait

        Erik Galavis
        +34 654 320 547
        Email Erik

        Related contents

        Congress passes US Farm Bill with Hemp Farming Act intact
        Confusion abounds in the tangle of US states’ CBD enforcement
        US attorney general favours bid to let states decide cannabis and CBD policy

        Latest content

        • Mexican CBD retailer sets itself up as market leader ahead of regulations
        • Greece: CBD and cannabis regulation, February 2023
        • If teenage cannabis use is rising, that has nothing to do with adult legalisation
        • Efsa denies waiting to follow US FDA’s lead on CBD safety in novel foods
        • 22nd Century Group acquires a UK cannabinoid distributor for $650K

        CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.

        Twitter Linkedin Youtube
        • Products and Services
          • Subscriptions
          • Shop
          • Customised Research
          • Telephone conference consultancy
        • About us
          • About CannIntelligence
          • Our services
          • Who we are
          • Media
          • Jobs
          • Contact us
          • Tamarind Intelligence Group
        © 2023 Tamarind Media Limited (T/A CannIntelligence)

        CannIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CannIntelligence, does not accept any liability or responsibility for information or views published.

        • Contact us
        • Terms & Conditions

        Start your FREE trial

        Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.

        Your display name will appear here.
        Please enter a username.
        Account Info
        Hide from Public
        Password must be at least 7 characters long. To make it stronger, use upper and lower case letters, numbers and symbols.
        Type your password again.
        Strength Indicator
        Hide from Public
        Please add a phone country prefix
        Hide from Public
        Hide from Public
        Hide from Public
        Hide from Public
        Hide from Public
        I agree to Terms and Conditions.

        START TRIAL

        By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.